|Videos|February 28, 2022
CORAL Study Brings Positive News for Adults With Depression
Author(s)Sagar V. Parikh, MD, FRCPC
Coadministration of zuranolone with a standard antidepressant yields positive outcomes.
Advertisement
Sagar Parikh, MD, FRCPC, shares news about the CORAL Study examining zuranolone treatment in patients with major depressive disorder, which demonstrated a rapid and statistically significant reduction in depressive symptoms at day 3 and over the 2-week treatment period.
To read more about this study, see:
Dr Parikh is a professor of Depression and Clinical Neuroscience, and Psychiatry Sciences, at the University of Michigan.
Newsletter
Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.
Advertisement
Related Content
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Psychiatric Times
1
Exiting Antidepressants: A Needed Spotlight on Withdrawal
2
Combatting the Opioid Crisis With Evidence-Based Treatments
3
A Digital Therapeutic (CT-152) as Adjunct To Antidepressant Medication: A Phase 3 Randomized Controlled Trial (the Mirai study)
4
“If I Had Legs I’d Kick You”: Maternal Mental Health, Stress, and Risk
5